Effect of a proprietary Magnolia and Phellodendronextract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial
Open Access
- 21 April 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nutrition Journal
- Vol. 7 (1), 11
- https://doi.org/10.1186/1475-2891-7-11
Abstract
Background: Recent research has established correlations between stress, anxiety, insomnia and excess body weight and these correlations have significant implications for health. This study measured the effects of a proprietary blend of extracts ofMagnolia officinalisandPhellodendron amurense (Relora®) on anxiety, stress and sleep in healthy premenopausal women.Methods: This randomized, parallel, placebo controlled clinical studywas conducted with healthy, overweight (BMI 25 to 34.9), premenopausal female adults, between the ages of 20 and 50 years, who typically eat more in response to stressful situations and scores above the national mean for women on self-reporting anxiety. The intervention wasRelora (250 mg capsules) or identical placebo 3 times daily for 6 weeks. Anxiety as measured by the Spielberger STATE-TRAIT questionnaires, salivary amylase and cortisol levels, Likert Scales/Visual Analog Scores for sleep quality and latency, appetite, and clinical markers of safety. The study was conducted by Miami Research Associates, a clinical research organization in Miami, FL.Results: The intent-to-treat population consisted of 40 subjects with 26 participants completing the study. There were no significant adverse events. Relora was effective, in comparison to placebo, in reducing temporary, transitory anxiety as measured by the Spielberger STATE anxiety questionnaire. It was not effective in reducing long-standing feelings of anxiety or depression as measured using the Spielberger TRAIT questionnaire. Other assessments conducted in this study including salivary cortisol and amylase levels, appetite, body morphology and sleep quality/latency were not significantly changed by Relora in comparison to placebo.Conclusion: This pilot study indicates that Relora may offer some relief for premenopausal women experiencing mild transitory anxiety. There were no safety concerns or significant adverse events observed in this study.Keywords
This publication has 13 references indexed in Scilit:
- Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in miceLife Sciences, 2007
- Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial.2006
- Sleep disorders in psychiatric practice.2005
- Short Sleep Duration Is Associated with Reduced Leptin, Elevated Ghrelin, and Increased Body Mass IndexPLoS Medicine, 2004
- Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: Interaction with drugs acting at 5-HT receptorsLife Sciences, 2004
- Minireview: Glucocorticoids—Food Intake, Abdominal Obesity, and Wealthy Nations in 2004Endocrinology, 2004
- Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behaviorPsychoneuroendocrinology, 2000
- Stress and Body Shape: Stress-Induced Cortisol Secretion Is Consistently Greater Among Women With Central FatPsychosomatic Medicine, 2000
- Identification of Magnolol and Honokiol as Anxiolytic Agents in Extracts of Saiboku-to, an Oriental Herbal MedicineJournal of Natural Products, 1998